Login/Sign Up
₹9375
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Tipanat 20 Tablet is a combination medication that contains Trifluridine, a nucleoside metabolic inhibitor, and Tipiracil, a thymidine phosphorylase inhibitor. It is used to treat patients with metastatic colorectal cancer who have been previously treated with other treatments, like chemotherapy.
Tipanat 20 Tablet is a combination medication that contains Trifluridine and Tipiracil. Trifluridine belongs to a group of drugs known as thymidine-based nucleoside analogues. It works by preventing cancer cells from growing and dividing. Tipiracil is a thymidine phosphorylase inhibitor. It helps by slowing down the breakdown of trifluridine in the body. Thus, it stays active longer and works more effectively against cancer cells.
Take Tipanat 20 Tablet in the dose and duration as advised by your doctor. Taking food with food at a fixed time is recommended to achieve maximum effect. Sometimes, you may experience nausea, vomiting, diarrhoea, stomach pain, headache, excessive tiredness, and muscle or bone pain. Most of these side effects of Tipanat 20 Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist, contact your doctor. Please consult your doctor immediately if you experience any allergic reactions or unusual symptoms.
It is not advisable to stop taking Tipanat 20 Tablet suddenly to avoid unpleasant side effects. The full course prescribed by the doctor should be completed. Inform your doctor if you have low white blood cell counts, anemia, bleeding problems, or liver and kidney disease.
Tipanat 20 Tablet is used in the treatment of metastatic colorectal cancer. The detailed use of Tipanat 20 Tablet is as follows:
Tipanat 20 Tablet is a combination medication, containing Trifluridine and Tipiracil. Trifluridine belongs to a group of drugs known as thymidine-based nucleoside analogues. It works by preventing cancer cells from growing and dividing. Tipiracil is a thymidine phosphorylase inhibitor. It helps by slowing down the breakdown of trifluridine in the body.
Consult your doctor
It is not known whether it is safe to consume alcohol with Tipanat 20 Tablet . However, as a precautionary measure, it is advisable to limit or avoid alcohol consumption. Consult your doctor for more information.
Caution
Consult the doctor before using Tipanat 20 Tablet in pregnancy as it may harm your fetus.
Caution
If you are breastfeeding, consult the doctor before using Tipanat 20 Tablet as it may pass into breast milk and harm your infant.
Caution
If you are taking Tipanat 20 Tablet , you should exercise caution when driving or performing any other activity because it may cause fatigue.
Caution
Tipanat 20 Tablet to be taken with caution, especially if you have a pre-existing or a history of liver disease.
Caution
Tipanat 20 Tablet to be given with caution, especially if you have a pre-existing or a history of kidney disease.
Consult your doctor
Safety and efficacy have not been established in children. Please consult your doctor about using Tipanat 20 Tablet in children.
Consult your doctor
If you have a heart disease or any related concerns, Please consult your doctor before using Tipanat 20 Tablet .
Consult your doctor
Please consult your doctor before giving Tipanat 20 Tablet to elderly people.
Have a query?
Inform your doctor if you are allergic to Trifluridine, Tipiracil, or any other of its components. Please inform your doctor if you face any difficulty while taking Tipanat 20 Tablet . Inform your doctor if you have low white blood cell counts, anemia, bleeding problems, or liver and kidney disease. Inform your doctor if you are pregnant or plan to become pregnant or breastfeed. Monitor blood counts regularly and adjust treatment as needed. Do not take any vaccines without a doctor’s advice, as they may interact. Always wear gloves to prevent exposure while handling Tipanat 20 Tablet .
Drug-Drug Interaction: This medication may have an interaction with monoclonal antibodies (like adalimumab, alemtuzumab, golimumab, and natalizumab), janus kinase inhibitors (abrocitinib, tofacitinib), tyrosine kinase inhibitors (deucravacitinib), sphingosine 1-phosphate receptor modulator (etrasimod), antirheumatic drugs (leflunomide), and vaccines (influenza virus vaccine, rotavirus vaccine, typhoid vaccine).
Drug-Food Interaction: No interactions were found.
Drug-Disease Interaction: Inform your doctor if you have low white blood cell counts, myelosuppression, anemia, bleeding problems, or liver and kidney disease.
Login/Sign Up
Login/Sign Up
Disclaimer
